- Home
- NATR vs JCE Comparison
NATR vs JCE Comparison
Compare NATR & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- JCE
- Stock Information
- Founded
- NATR 1972
- JCE 2007
- Country
- NATR United States
- JCE United States
- Employees
- NATR N/A
- JCE N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- JCE Trusts Except Educational Religious and Charitable
- Sector
- NATR Health Care
- JCE Finance
- Exchange
- NATR Nasdaq
- JCE Nasdaq
- Market Cap
- NATR 297.2M
- JCE 262.6M
- IPO Year
- NATR N/A
- JCE N/A
- Fundamental
- Price
- NATR $17.14
- JCE $15.74
- Analyst Decision
- NATR Strong Buy
- JCE
- Analyst Count
- NATR 2
- JCE 0
- Target Price
- NATR $20.50
- JCE N/A
- AVG Volume (30 Days)
- NATR 119.5K
- JCE 49.7K
- Earning Date
- NATR 11-06-2025
- JCE 01-01-0001
- Dividend Yield
- NATR N/A
- JCE 9.26%
- EPS Growth
- NATR N/A
- JCE N/A
- EPS
- NATR 0.75
- JCE N/A
- Revenue
- NATR $460,818,000.00
- JCE N/A
- Revenue This Year
- NATR $4.88
- JCE N/A
- Revenue Next Year
- NATR $2.66
- JCE N/A
- P/E Ratio
- NATR $22.89
- JCE N/A
- Revenue Growth
- NATR 4.33
- JCE N/A
- 52 Week Low
- NATR $11.01
- JCE $11.64
- 52 Week High
- NATR $18.06
- JCE $14.28
- Technical
- Relative Strength Index (RSI)
- NATR 61.82
- JCE 58.16
- Support Level
- NATR $16.13
- JCE $15.55
- Resistance Level
- NATR $17.64
- JCE $15.87
- Average True Range (ATR)
- NATR 0.51
- JCE 0.16
- MACD
- NATR 0.02
- JCE 0.01
- Stochastic Oscillator
- NATR 68.55
- JCE 59.37
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest
Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.